Uniphage aims to become a leader in curing fungal and bacterial diseases across agriculture and beyond. Our first goal is to reduce the use of dangerous fungicides, bactericides, and antibiotics in plant agriculture by developing significantly safer and more efficient microbe-based alternatives. Our current R&D program is focused on curing citrus greening disease, a bacterial disease crumbling the US citrus industry, and developing novel microbe-based solutions to cure fungal diseases.
- NSF SBIR Phase I
- Plug&Play Agritech Accelerator
- MassChallenge US, Summer 2021
- MassChallenge DoD-sponsored track
- MassChallenge & IBM AI Program
- Halcyon Fellow
- Panacea Stars Develop SS2021, Oxford University
- Project Enginuity, fall 2021 (SBIR Accelerator)
- Hangar Incubator by the National University of Singapore
- iGEM Venture Creation Lab
- Winner and Finalist in a range of startup competitions & Extensive non-dilutive funding recipient
- The most accurate & precise deep learning model to date to predict phages (safe viruses infecting bacteria only) to kill target bacterial pathogens
Company Details
- Founded
- -
- Address
- 7505 Fannin St, Ste. 610
- Industry
- Biotechnology
- Website
- uniphage.com
- Keywords
- IT Consulting.
- HQ
- Houston, Texas
Uniphage Inc. Questions
Uniphage Inc.'s website is uniphage.com
Uniphage Inc.'s LinkedIn profile is https://www.linkedin.com/company/uniphage
Uniphage Inc.'s industry is
Biotechnology
Uniphage Inc.'s top competitors are
Biotech Without Borders,
Aja Labs,
Pleigh™,
Crossing Minds,
Milestonex,
Solyn Bio,
Ashe Cosgrove,
Canaan Palestine,
Yara Shea Beauty,
Rheom Materials.
Uniphage Inc.'s categories are Biotechnology
Uniphage Inc.'s founding year is 2020
